Blacksmith Medicines
About:
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Website: https://blacksmithmedicines.com/
Top Investors: Eli Lilly, Alexandria Venture Investments, Evotec, National Institute of Allergy and Infectious Diseases, MP Healthcare Venture Management
Description:
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology. Over 30% of known enzymes are metalloenzymes, covering all major enzyme classes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases. Metal ions, including magnesium, zinc, iron, manganese and copper, are the essential ingredient in these metalloenzymes.
$3.3M
$1M to $10M
San Diego, California, United States
2017-01-01
amy(AT)juniper-point.com
Zachary Zimmerman
11-50
2024-02-21
Private
© 2025 bioDAO.ai